Eli Lilly and
LLY | NYSE
$1,417.54
+$43.84 (+3.19%)
At close: Oct 30, 2026, 4:02 PM ET
$1,411.01
-$6.53 (-0.46%)
Pre-market:
Nov 2, 2026, 5:43 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 46.58 | 65.65 | 99.99 | 55.68 | 47.22 | 26.10 |
PEG Ratio | 0.48 | 0.65 | -8.88 | 4.52 | -4.93 | -1.02 |
PS Ratio | 14.81 | 15.44 | 15.36 | 12.18 | 9.30 | 6.58 |
PB Ratio | 36.37 | 48.99 | 48.67 | 32.64 | 29.34 | 28.63 |
P/FCF Ratio | 107.56 | 184.91 | -166.33 | 75.56 | 48.89 | 36.13 |
P/OCF Ratio | 57.40 | 78.85 | 123.64 | 45.82 | 35.76 | 24.85 |
OCF/S Ratio | 25.80 | 19.58 | 12.43 | 26.58 | 26.01 | 26.49 |
Debt / Equity Ratio | 1.60 | 2.37 | 2.34 | 1.52 | 1.88 | 2.94 |
Quick Ratio | 1.19 | 0.89 | 0.73 | 0.80 | 0.97 | 1.08 |
Current Ratio | 1.58 | 1.15 | 0.94 | 1.05 | 1.23 | 1.40 |
Asset Turnover | 0.58 | 0.57 | 0.53 | 0.58 | 0.58 | 0.53 |
Interest Coverage | 37.34 | 21.83 | 22.20 | 26.10 | 23.35 | 20.05 |
Return on Equity | 77.78% | 74.62% | 48.65% | 58.64% | 62.16% | 109.79% |
Return on Assets | 18.35% | 13.45% | 8.19% | 12.62% | 11.44% | 13.28% |
Return on Invested Capital | 30.20% | 25.66% | 19.77% | 23.45% | 20.38% | 18.08% |
Dividend Yield | 0.56% | 0.67% | 0.78% | 1.02% | 1.17% | 1.66% |
Payout Ratio | 26.09% | 44.20% | 77.65% | 56.62% | 55.30% | 43.38% |
FCF Payout Ratio | 64.51% | 150.28% | -107.64% | 83.60% | 61.19% | 64.56% |
Gross Profit Margin | 83.04% | 81.31% | 79.25% | 76.77% | 74.18% | 77.66% |
Net Profit Margin | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% | 25.24% |
Pretax Profit Margin | 39.48% | 28.15% | 19.21% | 23.85% | 21.74% | 29.46% |
Operating Profit Margin | 45.56% | 37.83% | 31.61% | 30.32% | 28.01% | 29.38% |
FCF Margin | 13.77% | 8.35% | -9.24% | 16.12% | 19.02% | 18.22% |
EBITDA Margin | 48.62% | 41.75% | 25.11% | 30.34% | 28.40% | 36.32% |
Add to Watchlist
Select watchlists to add or remove LLY